19736 S0214 M1 1571
Document text
BioNTech SE 02/15/2021 An der Goldgrube 12 Mainz Rhineland-Palatinate Germany 55131215-280-5503 COVID-19 Vaccine (BNT162, PF-07302048) 019736 Prophylactic immunization against COVID-19 in adults 16 years of age 0 2 1 3 Summary Monthly Safety Report (SMSR) 3 FDA-CBER-2021 5683-1079254 Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Elisa Harkins, Global Regulatory Lead, Pfizer Global Regulatory Affairs - Vaccines 215-280-5503 (845) 474-3500 500 Arcola Road Collegeville PA United States of America [email protected] 02/15/2021 United States of America 3 (b) (6) FDA-CBER-2021-5683-1079255 3 FDA-CBER-2021-5683-1079256